Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acura Pharmaceuticals Inc.

www.acurapharm.com

Latest From Acura Pharmaceuticals Inc.

Firms Spread Diaper Rash, Skin Care Brands, Move Lice Kit License In OTC Sector Deals

Randob Labs agreed to purchase the Balmex brand of baby and adult skin protectants from Moberg Pharma for $4.25m. Mission Pharmacal divested to MainPointe topical analgesic brand Thera-Gesic and the Dr. Smith’s line of infant and adult skin protectant ointments and sprays.

US States United States

Firms Spread Diaper Rash, Skin Care Brands, Move Lice Kit License In OTC Sector Deals

Randob Labs agreed to purchase the Balmex brand of baby and adult skin protectants from Moberg Pharma for $4.25m. Mission Pharmacal divested to MainPointe topical analgesic brand Thera-Gesic and the Dr. Smith’s line of infant and adult skin protectant ointments and sprays.

US States United States

Firms Spread Diaper Rash, Skin Care Brands, Move Lice Kit License In Recent Deals

Mission Pharmacal divested to MainPointe Pharmaceuticals topical analgesic brand Thera-Gesic and the Dr. Smith’s line of infant and adult skin protectant ointments and sprays. Randob Labs agreed to purchase the Balmex brand of baby and adult skin protectants from Moberg Pharma for $4.25m.
Commercial US States

Perrigo Recalls Tamper-Resistant PSE Product Due To Contamination

FDA on Dec. 21 identified the recall as class II, for violative products that may cause temporary or medically reversible adverse health consequences though the probability of serious consequences is remote. Perrigo acquired the Zephrex-D brand and rights to the formulation in 2016.

FDA Manufacturing
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
    • OTC, Consumer
  • Therapeutic Areas
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Halsey Drug Co. Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Acura Pharmaceuticals Inc.
  • Senior Management
  • Bob Jones, Pres. & CEO
    Peter A Clemens, SVP, CFO
    James F Emigh, VP, Corp. Dev.
  • Contact Info
  • Acura Pharmaceuticals Inc.
    Phone: (847) 705-7709
    616 N. North Ct.
    Ste. 120
    Palatine, IL 60067
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register